| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |